Publication details
The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic
| Authors | |
|---|---|
| Year of publication | 2017 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Meeting abstract The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic. |